Comparative efficacy and safety of different tranexamic acid administration in spine surgery: a network meta-analysis
European Spine Journal · 2026-04 · 35 (4) · 1984-2000
DOI: 10.1007/s00586-025-09161-9 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Spine Journal, online erschienen am 31.07.2025. Verfasst von Bin Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Tranexamic Acid, Antifibrinolytic Agents, Blood Loss, Surgical, Spine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Tranexamic acid (TXA) is widely used to reduce blood loss in spine surgery. Different administration routes, including intravenous (IV), topical, and oral, have been studied, but a comprehensive comparison of their efficacy and safety remains lacking. This network meta-analysis aims to compare the effectiveness and safety of various TXA administration methods in spine surgery, focusing on blood loss, transfusion rates and other perioperative parameters. METHODS: We systematically reviewed randomized controlled trials (RCTs) published until January 2025, comparing different TXA regimens in spine surgery. Data on blood loss, transfusion rates, postoperative complications, post-drainage, length of hospital stay and operative time are extracted. A network meta-analysis is conducted using a Bayesian random effects model to rank the efficacy and safety of TXA routes. RESULTS: A total of 12 RCTs involving 1980 patients are included. Topical TXA + IV TXA demonstrated the highest efficacy in reducing intraoperative blood loss, post-operative blood loss, overall blood loss, Hct, Hgb, transfusion rates, post-drainage, operative time and hospital stay, with the highest probability of being the best treatment. Oral TXA showed fewer complications, making it a safer option for low-risk patients. Subgroup analysis confirmed the superiority of topical TXA + IV TXA in spine fusion surgeries, particularly for overall blood loss control and reducing transfusion requirements. CONCLUSION: For open thoracolumbar fusion surgery, Topical TXA + IV TXA is the most effective regimen for reducing blood loss and enhancing recovery in high-risk surgeries. Oral TXA offers a safer alternative for low-risk patients. Extrapolating these findings to other spine procedures still requires further randomized controlled trials. Tailoring TXA administration to individual patient needs optimizes outcomes and reduces complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peking University People's Hospital, Beijing, China.
- Peking University People's Hospital, Beijing, China. liuhaiying1964@163.com.
Zitieren
APA
Zheng, B., Zhu, Z., Yu, P., Liang, Y., Li, G., & Liu, H. (2026). Comparative efficacy and safety of different tranexamic acid administration in spine surgery: a network meta-analysis. European Spine Journal, 35(4), 1984-2000. https://doi.org/10.1007/s00586-025-09161-9
Vancouver
Zheng B, Zhu Z, Yu P, Liang Y, Li G, Liu H. Comparative efficacy and safety of different tranexamic acid administration in spine surgery: a network meta-analysis. European Spine Journal. 2026;35(4):1984-2000. doi:10.1007/s00586-025-09161-9
BibTeX
@article{Zheng2026,
author = {Zheng, Bin and Zhu, Zhenqi and Yu, Panfeng and Liang, Yan and Li, Gen and Liu, Haiying},
title = {Comparative efficacy and safety of different tranexamic acid administration in spine surgery: a network meta-analysis},
journal = {European Spine Journal},
year = {2026},
volume = {35},
number = {4},
pages = {1984--2000},
doi = {10.1007/s00586-025-09161-9}
}
EUVIMED